Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • Resource and Technical Advances
    • Clinical Medicine
    • Reviews
    • Editorials
    • Perspectives
    • Top read articles
  • JCI This Month
    • Current issue
    • Past issues

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Concise Communication
  • Editorials
  • Viewpoint
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Transfers
  • Advertising
  • Job board
  • Contact
Piezo1 incorporates mechanical force signals into the genetic program that governs lymphatic valve development and maintenance
Dongwon Choi, … , Il-Taeg Cho, Young-Kwon Hong
Dongwon Choi, … , Il-Taeg Cho, Young-Kwon Hong
Published January 24, 2019
Citation Information: JCI Insight. 2019;4(5):e125068. https://doi.org/10.1172/jci.insight.125068.
View: Text | PDF
Research Article Vascular biology

Piezo1 incorporates mechanical force signals into the genetic program that governs lymphatic valve development and maintenance

  • Text
  • PDF
Abstract

The lymphatic system plays crucial roles in tissue homeostasis, lipid absorption, and immune cell trafficking. Although lymphatic valves ensure unidirectional lymph flows, the flow itself controls lymphatic valve formation. Here, we demonstrate that a mechanically activated ion channel Piezo1 senses oscillating shear stress (OSS) and incorporates the signal into the genetic program controlling lymphatic valve development and maintenance. Time-controlled deletion of Piezo1 using a pan-endothelial Cre driver (Cdh5[PAC]-CreERT2) or lymphatic-specific Cre driver (Prox1-CreERT2) equally inhibited lymphatic valve formation in newborn mice. Furthermore, Piezo1 deletion in adult lymphatics caused substantial lymphatic valve degeneration. Piezo1 knockdown in cultured lymphatic endothelial cells (LECs) largely abrogated the OSS-induced upregulation of the lymphatic valve signature genes. Conversely, ectopic Piezo1 overexpression upregulated the lymphatic valve genes in the absence of OSS. Remarkably, activation of Piezo1 using chemical agonist Yoda1 not only accelerated lymphatic valve formation in animals, but also triggered upregulation of some lymphatic valve genes in cultured LECs without exposure to OSS. In summary, our studies together demonstrate that Piezo1 is the force sensor in the mechanotransduction pathway controlling lymphatic valve development and maintenance, and Piezo1 activation is a potentially novel therapeutic strategy for congenital and surgery-associated lymphedema.

Authors

Dongwon Choi, Eunkyung Park, Eunson Jung, Boksik Cha, Somin Lee, James Yu, Paul M. Kim, Sunju Lee, Yeo Jin Hong, Chester J. Koh, Chang-Won Cho, Yifan Wu, Noo Li Jeon, Alex K. Wong, Laura Shin, S. Ram Kumar, Ivan Bermejo-Moreno, R. Sathish Srinivasan, Il-Taeg Cho, Young-Kwon Hong

×

Figure 5

Ectopic expression of Piezo1 induces lymphatic valve signature genes.

Options: View larger image (or click on image) Download as PowerPoint
Ectopic expression of Piezo1 induces lymphatic valve signature genes.
(A...
(A and B) Primary LECs were transfected with a Piezo1/EGFP-expressing plasmid and cultured for 48 hours without OSS, before immunostaining for lymphatic valve genes FOXC2, GATA2, CX37, LAMA5, and ITGA9. (A) Arrowheads point to transfected EGFP+ (thus Piezo1-overexpressing) cells, whereas arrows point to EGFP–, untransfected cells. O/E, overexpression; LV, lymphatic valve. (B) The intensity of these cells was measured and charted in a box-and-whisker plot. (C and D) Expression of the lymphatic valve genes in LECs that were transfected with a control (CTR) or Piezo1/EGFP-expressing plasmid (Piezo1) was determined by qRT-PCR after (C) 24 hours, or by Western blot assay after (D) 48 hours, in the absence of OSS. The box plots depict the minimum and maximum values (whiskers), the upper and lower quartiles, and the median. The length of the box represents the interquartile range. Scale bars: 50 μm (A). **P < 0.01; ***P < 0.001; unpaired, 2-tailed t test compared with (B) the untransfected cells or (C) the control plasmid.

Copyright © 2022 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts